Trial intelligence / Profile preview

Effect of oxcarbazepine (Trileptal) on corticosteroid metabolism – pilot study

2007-003913-15Phase 4Completed

Sponsor
Medical University of Innsbruck
Start
Oct 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of oxcarbazepine in temporal lobe epilepsy (TLE), sponsored by Medical University of Innsbruck. Primary endpoint: Total degradation markers of endogenous cortisol. Started Oct 2007; status: completed.

02

Drugs

oxcarbazepine
03

Conditions

temporal lobe epilepsy (TLE)

Beyond the preview

Go deeper on 2007-003913-15.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-003913-15.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call